Gene: ZRANB2
Official Full Name: zinc finger RANBP2-type containing 2provided by HGNC
Gene Summary: Enables RNA binding activity. Predicted to be involved in RNA splicing and mRNA processing. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33258 | ZRANB2 Knockout cell line (HeLa) | Human | ZRANB2 | 1:3~1:6 | Negative | Online Inquiry |
KO33259 | ZRANB2 Knockout cell line (HCT 116) | Human | ZRANB2 | 1:2~1:4 | Negative | Online Inquiry |
KO33260 | ZRANB2 Knockout cell line (HEK293) | Human | ZRANB2 | 1:3~1:6 | Negative | Online Inquiry |
KO33261 | ZRANB2 Knockout cell line (A549) | Human | ZRANB2 | 1:3~1:4 | Negative | Online Inquiry |
ZRANB2 Gene Knockout Cell Lines are a revolutionary tool designed for researchers investigating the crucial functions of the ZRANB2 gene, which encodes a member of the zinc-dependent RNA-binding protein family involved in various cellular processes, including mRNA metabolism, DNA repair, and stress response. By generating these knockout cell lines, scientists can explore the specific role of the ZRANB2 gene in cellular functions and its implication in diseases such as cancer, neurodegeneration, and other genetic disorders.
The mechanisms behind the ZRANB2 knockout involve targeted gene editing through advanced CRISPR-Cas9 technology, enabling precise deletion of the ZRANB2 gene in various cell types. This allows for the examination of downstream effects on cellular pathways and gene expression profiles. The resulting knockout models are invaluable in elucidating the biological role of ZRANB2, providing insights into mRNA processing, ribosome biogenesis, and chromatin remodeling, which are critical for maintaining cellular homeostasis.
In terms of scientific importance, these knockout cell lines enhance research capabilities in both basic and applied biology. In clinical settings, they offer a platform for drug discovery, allowing researchers to screen compounds that may target ZRANB2-related pathways or compensate for its loss, thus advancing personalized medicine strategies.
When compared to alternative models like transient knockdown or full organism models, ZRANB2 Gene Knockout Cell Lines provide a more stable expression background, leading to reproducible results and more straightforward interpretation of phenotypic outcomes. Additionally, they allow for high-throughput screening applications, necessitating fewer resources and time in research workflows.
Choosing ZRANB2 Gene Knockout Cell Lines reflects a commitment to cutting-edge research methodologies. With our established expertise in gene editing technology and comprehensive support, we empower researchers and clinicians to delve deeper into the complexities of gene function and to expedite the discovery of therapeutic strategies aimed at overcoming related diseases.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.